Johnson Matthey PLC (LON:JMAT – Get Free Report) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,623.91 ($20.22) and traded as high as GBX 1,782 ($22.18). Johnson Matthey shares last traded at GBX 1,767 ($22.00), with a volume of 291,103 shares traded.
Wall Street Analysts Forecast Growth
JMAT has been the topic of several recent research reports. Numis Securities reaffirmed a “buy” rating and issued a GBX 2,200 ($27.39) price objective on shares of Johnson Matthey in a research note on Wednesday, March 20th. Jefferies Financial Group reissued a “buy” rating and issued a GBX 2,100 ($26.14) target price on shares of Johnson Matthey in a research report on Wednesday, March 20th. Finally, Berenberg Bank lifted their target price on shares of Johnson Matthey from GBX 1,650 ($20.54) to GBX 1,800 ($22.41) and gave the stock a “hold” rating in a research report on Monday, April 8th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of GBX 2,010 ($25.02).
Get Our Latest Report on Johnson Matthey
Johnson Matthey Trading Down 1.7 %
Insider Buying and Selling at Johnson Matthey
In related news, insider Stephen Oxley acquired 18 shares of the company’s stock in a transaction on Wednesday, March 20th. The shares were purchased at an average price of GBX 1,864 ($23.20) per share, for a total transaction of £335.52 ($417.68). Company insiders own 0.60% of the company’s stock.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Featured Stories
- Five stocks we like better than Johnson Matthey
- Best Stocks Under $10.00
- Silicon Motion Proves That AI in Motion Stays in Motion
- What Investors Need to Know About Upcoming IPOs
- Undervalued UnitedHealth Group Won’t Be For Long
- What is Insider Trading? What You Can Learn from Insider Trading
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.